Table 2 Baseline characteristics of the study subjects
Men (n = 251) | Women (n = 302) | |
|---|---|---|
Anthropometrics | ||
Age | 37.1 ± 0.9 | 37.3 ± 0.8 |
Weight (kg) | 74.5 ± 1.0 | 65.9 ± 0.9 |
Height (cm) | 165.8 ± 0.4 | 154.0 ± 0.3 |
BMI (Kg/m2) | 27 ± 0.3 | 28 ± 0.4 |
Hypercholesterolemia (n,% of total) | 22 (9%) | 21 (7%) |
Plasma Lipids | ||
Total Cholesterol (mmol/L) | 4.94 ± 0.06 | 5.04 ± 0.05 |
HDL- Cholesterol (mmol/L) | 1.48 ± 0.02 | 1.79 ± 0.03 |
LDL- Cholesterol (mmol/L) | 2.89 ± 0.06 | 2.74 ± 0.05 |
Total/HDL- Cholesterol ratio | 3.52 ± 0.07 | 2.96 ± 0.05 |
Triglycerides (mmol/L) | 1.25 ± 0.04 | 1.11 ± 0.04 |
ApoB100 (mmol/L) | 0.97 ± 0.02 | 0.93 ± 0.01 |
ApoA1 (mmol/L) | 1.62 ± 0.02 | 1.77 ± 0.02 |
n -3 PUFA in RBCs | ||
Eicosapentaenoic acid (EPA) (%) | 1.52 ± 0.08 | 1.82 ± 0.07 |
Docosapentaenoic acid (DPA) (%) | 2.17 ± 0.03 | 2.21 ± 0.03 |
Docosahexaenoic acid (DHA) (%) | 5.11 ± 0.12 | 5.80 ± 0.11 |
Total n-3 PUFAs (%) | 9.14 ± 0.22 | 10.19 ± 0.20 |
Daily Intake | ||
Total Energy Intake (KJ) | 10932 ± 352 | 9291 ± 301 |